Rare diseases
Investigational molecules
Locations
Back to Croatia85 clinical trials in Osijek, Croatia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
CroatiaStudy of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo
CroatiaStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
CroatiaStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease
CroatiaStudy on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis
CroatiaStudy on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease
CroatiaStudy Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy
CroatiaCroatiaStudy on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis
CroatiaStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
CroatiaA study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes
CroatiaStudy on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for psoriatic arthritis, systemic sclerosis, and Sjögren's Syndrome. Studies evaluate new therapeutic approaches targeting specific immune pathways.
Investigations include both biologic and non-biologic treatment options for patients with varying disease severity.
Comprehensive studies examining treatments for Crohn's Disease and Ulcerative Colitis. Research focuses on novel therapeutic compounds and combination treatments.
Trials aim to improve clinical outcomes and quality of life for patients with moderate to severe disease.
Advanced research into Multiple Sclerosis and tardive dyskinesia treatments. Studies evaluate new therapeutic approaches and compare treatment efficacy.
Focus on developing treatments that can slow disease progression and improve symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
